Oren Feder, MD
Orthopaedic Surgery · Rutherford, NJNPI 1972037729
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,200 of the $9,895 with a category attached, or 72.8%. Smith+Nephew accounts for 75.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $4,953 and has fallen 90.0% since, to $498 in 2025.
Across 45 payments — averaging $219.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$7K
- Stryker$2K
- Zimmer Biomet$207
- Innovation Technologies Inc$163
- Davol Inc.$136
- Globus Medical$127
- plus $49 from 2 others
What the payments were for
- Food & beverage$2,69527%
- Education$7,20073%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 7 | $7,457 |
| Stryker | 31 | $1,757 |
| Zimmer Biomet | 2 | $207 |
| Innovation Technologies Inc | 1 | $163 |
| Davol Inc. | 1 | $136 |
| Globus Medical | 1 | $127 |
| Exactech, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$961
- ACCOLADE$541
- TRIATHLON$541
- Irrisept$163
- Affixus$137
- Surgiphor$136
- A/R Femoral Nail$127
- Journey II$115
How this compares
$9,895 in reported general payments places this provider in the 70th percentile of 587 orthopaedic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 57 | $3,762 |
| Celecoxib | 65 | $1,270 |
| Meloxicam | 97 | $238 |
| Pantoprazole Sodium | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Rutherford
- Michael KellyHackensack$9.7M
- Mark HartzbandParamus$9.4M
- Randal BetzLawrenceville$3M
- Luke AustinSewell$2.9M
- Kenneth MontgomeryMorristown$2.7M
- Zachary PostEgg Harbor Township$1.7M
- Harlan LevineMontvale$1.5M
- Jeffrey AbramsPrinceton$1.5M
- Gregg KleinParamus$1.5M
- David NazarianMarlton$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.